MRSE


Also found in: Acronyms.

MRSE

Methicillin-resistant Staphylococcus epidermidis.
Mentioned in ?
References in periodicals archive ?
PNSP, MRSE and MRGAS were chosen as indicator organistas for those effects.
MX-2401 is a novel lipopeptide agent in development as an improved treatment for patients infected with life-threatening strains of Staphylococcus, including MRSA (methicillin-resistant Staphylococcus aureus) and MRSE (methicillin-resistant Staphylococcus epidermidis).
The MRSE dust collector can be installed either outdoors or inside and offers quiet, high-performance dust collection, according to Murphy-Rodgers Inc.
Vancomycin is one of the few treatments available to hospital patients infected with difficult-to-treat strains of Staphylococcus bacteria, or Staph known as MRSA (methicillin-resistant Staphylococcus aureus) and MRSE (methicillin-resistant Staphylococcus epidermidis).
5 diopter change in refraction based on the MRSE (manifest refraction spherical equivalent) from baseline, all of which are reflective of changes in BCVA (both positive and negative) that are not associated with AMD.
EPA registered claims for KinderGuard include a 30 second kill time and a 24 hour residual kill on standard indicator bacteria, a 2 minute kill time on the resistant bacteria MRSE and VRE, a 10 minute kill time on fungi, a 30 second kill time on HIV Type I, and a 10 minute kill time on other viruses.
EPA approved claims for Axen30 include a 30 second kill time and a 24 hour residual kill on standard indicator bacteria, a two minute kill time on the resistant bacteria MRSE and VRE, a 10 minute kill time on fungi, a 30 second kill time on HIV Type I, and a 10 minute kill time on other viruses.
Dalbavancin, a novel next-generation glycopeptide agent, belongs to the same class as vancomycin, the most widely-used and one of the few treatments available to patients infected with the most difficult-to- treat strains of Staph: MRSA (methicillin-resistant Staphylococcus aureus) and MRSE (methicillin-resistant Staphylococcus epidermidis).
Dalbavancin, a novel next generation glycopeptide agent, belongs to the same class as vancomycin, the most widely-used and one of the few treatments available to patients infected with the most difficult-to- treat strains of Staph: MRSA and MRSE (methicillin-resistant Staphylococcus epidermidis).